Phathom Pharmaceuticals(PHAT)
$6.28+0.83 (+15.34%)
PHAT
Phathom Pharmaceuticals hedge funds
$6.28
At close:+0.83 (+15.34%)
Want to see PHAT full AI Analyst Report?
Phathom Pharmaceuticals (PHAT) Hedge Fund Trading Activity
608 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 65.6K Shares Last Quarter
Hedge Fund Holdings in PHAT
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Added | 11.40% | $49,097,650 | <0.01% | ||||
| Woodline Partners LP | Not Changed | 0.00% | $4,004,214 | 0.01% | |||
| Gilder Gagnon Howe & Co LLC. | Reduced | -37.00% | $956,254 | <0.01% | |||
| Perceptive Advisors LLC | Reduced | -42.49% | $5,772,200 | 0.09% | |||
| Hussman Strategic Advisors Inc | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Phathom Pharmaceuticals?
The hedge funds that hold the most shares in Phathom Pharmaceuticals are Joseph Edelman, John Hussman and BlackRock, Inc..
Are hedge funds buying or selling PHAT?
In the last quarter hedge funds have Decreased their holdings in Phathom Pharmaceuticals by 65.6K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Phathom Pharmaceuticals stock?
Warren Buffet currently does not own shares in Phathom Pharmaceuticals.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here

